论文信息 - Excellent Outcomes at 3 Years with Nilotinib 800 Mg Daily In Early Chronic Phase, Ph+ Chronic Myeloid Leukemia (CML): Results of a Phase 2 GIMEMA CML WP Clinical Trial - 字舞流文

Excellent Outcomes at 3 Years with Nilotinib 800 Mg Daily In Early Chronic Phase, Ph+ Chronic Myeloid Leukemia (CML): Results of a Phase 2 GIMEMA CML WP Clinical Trial

M. Baccarani | G. Rosti | G. Martinelli | A. Cuneo | G. Saglio | S. Soverini | F. Pane | N. Testoni | M. Breccia | G. Alimena | G. Specchia | M. Tiribelli | F. Stagno | F. Castagnetti | G. Gugliotta | T. Intermesoli | B. Martino | M. Bocchia | M. Amabile | A. Zaccaria | F. Palandri | L. Levato | M. Cedrone | A. Capucci | F. Porretto